Director/PDMR Shareholding

RNS Number : 8595E
GlaxoSmithKline PLC
13 April 2011
 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

 

 

The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 12 April 2011 of an increase in their notional interests in Ordinary shares at a price of £12.22 per share and ADRs at a price of $39.96 per ADR following the notional re-investment of the dividend paid to shareholders on 7 April 2011.

 

 


Ordinary shares

ADRs

Mr A P Witty

5097.75


Dr M M Slaoui


1219.01

Mr S M Bicknell

158.12


Mr J M Clarke

1371.08


Mr M Dunoyer

516.38


Mr E J Gray

890.31


Mr S A Hussain

790.64


Mr W C Louv


441.67

Dr D Pulman


441.67

Mr D S Redfern

210.11


Mr J R Stéphenne

473.65


Ms C Thomas

158.12


Mr D E Troy


984.75

Dr P J T Vallance

652.78


Mrs V A Whyte

37.75


 

 

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rules 3.1.4R(1)(a).

 

 

 

V A Whyte

Company Secretary

 

13 April 2011

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSXXLFFFZFZBBF

Companies

GSK (GSK)
UK 100

Latest directors dealings